Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Start Date Set For Bundling, Gainsharing Program For Hip, Knee Implants

This article was originally published in The Gray Sheet

Executive Summary

CMS gave hospitals and other providers more time to prepare for an expanding bundled payment program targeting hip and knee implant procedures, moving a proposed Jan. 1 start date to April.

You may also be interested in...



Boston Scientific Thinks Big In Heart Failure Risk-Share Plan

Value-based care and leveraging digital health and analytics are now viewed as the all-important ingredients in sustainable health care delivery. With that in mind, Boston Scientific and global professional services company Accenture recently joined forces in a total-cost-of-care heart failure project that is rewarded on patient outcomes.

Policy Briefs: What's New From FDA And CMS

Updates include an FDA safety communication for the Lariat suture device addressing use for left atrial appendage closure, new FDA draft guidance documents, and CMS proposals to cut radiation therapy payments and launch new payment models for hip and knee replacements.

QUOTED. 27 November 2020. Agam Sharda.

The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.

Topics

UsernamePublicRestriction

Register

LL018264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel